Back to News
Market Impact: 0.15
De la Chine à la scène internationale : Hengrui présente ses recherches novatrices au congrès de l'ESMO 2026 et explore de nouvelles approches en oncologie
Source: PR Newswire
Healthcare & BiotechCorporate Guidance & Outlook
Hengrui reported a record 64 research presentations at the 2026 European Society for Medical Oncology congress, highlighting its oncology R&D activity and growing international reach. The provided article excerpt contains no clinical results, financial figures, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- PC chip plunge wipes out a quarter of Intel’s value
- Intel plunges on a major guidance miss. What went wrong — and how to proceed
- FedEx Freight delivers a much-needed quarterly beat. Where we stand on shares now
- We're cutting our Amazon price target after a tough quarter. But it isn't all bad